양지원 (울산대학교 의과대학, 서울아산병원)님 | 한빛사연구자 > 한빛사

울산대학교 의과대학, 서울아산병원

최종업데이트 2025.02.26.

Impact of newer antihyperglycemic agents on hepatic complications: A systematic review and meta-analysis of data from 5.3 million patients with type 2 diabetes mellitus
- Hepatology, Jan 29 2026, | https://doi.org/10.1097/HEP.0000000000001695
- 2026-01
- 의약학
- 한빛사논문
Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular Carcinoma
- Liver Cancer, October 16 2024 | https://doi.org/10.1159/000541621
- 2024-10
- 의약학
- 한빛사논문
Validation of The Model for End-Stage Liver Disease 3.0 in Korean Patients on the Liver Transplant Waiting List
- Clin. Gastroenterol. Hepatol., Published:January 31, 2023 | https://doi.org/10.1016/j.cgh.2023.01.020
- 2023-01
- 의약학
- 한빛사논문
Low level of hepatitis B viremia compared with undetectable viremia increases the risk of hepatocellular carcinoma in patients with untreated compensated cirrhosis
- Am. J. Gastroenterol., 2023 Jan 9 | doi: 10.14309/ajg.0000000000002181
- 2023-01
- 의약학
- 한빛사논문

연구자 ID

저자논문